Moderna (MRNA)

Moderna (MRNA) Stock Price & Analysis


MRNA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$115.03 - $217.25
Previous Close$126.24
Average Volume (3M)3.45M
Market Cap
Enterprise Value$40.13B
Total Cash (Recent Filing)$8.92B
Total Debt (Recent Filing)$927.00M
Price to Earnings (P/E)10.9
Aug 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)11.59
Shares Outstanding381,209,341
10 Day Avg. Volume3,674,397
30 Day Avg. Volume3,454,828
Standard Deviation0.28
Financial Highlights & Ratios
Price to Book (P/B)2.68
Price to Sales (P/S)25.84
Price to Cash Flow (P/CF)-10.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.16
Enterprise Value/Gross Profit2.90
Enterprise Value/Ebitda11.28
Price Target Upside81.90% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Moderna’s price range in the past 12 months?
Moderna lowest stock price was $115.03 and its highest was $217.25 in the past 12 months.
    What is Moderna’s market cap?
    Currently, no data Available
    When is Moderna’s upcoming earnings report date?
    Moderna’s upcoming earnings report date is Aug 09, 2023 which is in 73 days.
      How were Moderna’s earnings last quarter?
      Moderna released its earnings results on May 04, 2023. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of -$1.747 by $1.937.
        Is Moderna overvalued?
        According to Wall Street analysts Moderna’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Moderna pay dividends?
          Moderna does not currently pay dividends.
          What is Moderna’s EPS estimate?
          Moderna’s EPS estimate is -$3.97.
            How many shares outstanding does Moderna have?
            Moderna has 381,209,350 shares outstanding.
              What happened to Moderna’s price movement after its last earnings report?
              Moderna reported an EPS of $0.19 in its last earnings report, beating expectations of -$1.747. Following the earnings report the stock price went up 3.22%.
                Which hedge fund is a major shareholder of Moderna?
                Among the largest hedge funds holding Moderna’s share is Flagship Pioneering Inc.. It holds Moderna’s shares valued at 2B.


                  Moderna Stock Smart Score

                  The Moderna stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  Incorporated in 2010, Massachusetts-based Moderna, Inc. is a clinical stage biotechnology company which develops therapeutics and vaccines based on messenger ribonucleic acid (mRNA) for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.


                  Top 5 ETFs holding MRNA

                  Market Value
                  Smart Score
                  Vanguard S&P 500 ETF
                  Invesco QQQ Trust
                  SPDR S&P 500 ETF Trust
                  SPDR S&P 500 ETF Trust CDI
                  iShares Core S&P 500 ETF
                  Up to five ETFs with an Outperform Smart Score that hold MRNA. The ETFs are listed according to market value of MRNA within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Gilead Sciences
                  Vertex Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis